VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 66 filers reported holding VIKING THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,605 | -91.3% | 1,500 | -94.4% | 0.00% | – |
Q2 2023 | $190,108 | -4.2% | 26,599 | +8.0% | 0.00% | – |
Q1 2023 | $198,503 | +93.8% | 24,637 | +58.2% | 0.00% | – |
Q4 2022 | $102,447 | -38.3% | 15,575 | -32.2% | 0.00% | – |
Q2 2020 | $166,000 | -16.6% | 22,973 | -46.0% | 0.00% | -100.0% |
Q1 2020 | $199,000 | -37.2% | 42,573 | +7.6% | 0.00% | 0.0% |
Q4 2019 | $317,000 | +3.3% | 39,573 | -11.4% | 0.00% | 0.0% |
Q3 2019 | $307,000 | -7.8% | 44,673 | +11.4% | 0.00% | 0.0% |
Q2 2019 | $333,000 | -14.4% | 40,112 | +2.6% | 0.00% | 0.0% |
Q1 2019 | $389,000 | +56.2% | 39,100 | +19.9% | 0.00% | 0.0% |
Q4 2018 | $249,000 | -35.3% | 32,600 | -63.0% | 0.00% | -50.0% |
Q1 2018 | $385,000 | +35.6% | 88,140 | +25.9% | 0.00% | +100.0% |
Q4 2017 | $284,000 | +1394.7% | 70,000 | +600.0% | 0.00% | – |
Q3 2017 | $19,000 | +90.0% | 10,000 | +233.3% | 0.00% | – |
Q4 2015 | $10,000 | -44.4% | 3,000 | 0.0% | 0.00% | – |
Q3 2015 | $18,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |